메뉴 건너뛰기




Volumn 58, Issue 5, 2012, Pages 837-845

The promise of angiogenic markers for the early diagnosis and prediction of preeclampsia

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ENDOGLIN; PLACENTAL GROWTH FACTOR; PREGNANCY ASSOCIATED PLASMA PROTEIN A; SOLUBLE FMS LIKE TYROSINE KINASE 1; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

EID: 84860699673     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2011.169094     Document Type: Review
Times cited : (103)

References (84)
  • 1
    • 20444409135 scopus 로고    scopus 로고
    • Latest advances in understanding preeclampsia
    • DOI 10.1126/science.1111726
    • Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science 2005;308: 1592-4. (Pubitemid 40807500)
    • (2005) Science , vol.308 , Issue.5728 , pp. 1592-1594
    • Redman, C.W.1    Sargent, I.L.2
  • 3
    • 0034619029 scopus 로고    scopus 로고
    • Pre-eclampsia
    • Walker JJ. Pre-eclampsia. Lancet 2000;356: 1260-5.
    • (2000) Lancet , vol.356 , pp. 1260-5
    • Walker, J.J.1
  • 6
    • 0035938977 scopus 로고    scopus 로고
    • Pregnancy complications and maternal risk of ischaemic heart disease: A retrospective cohort study of 129 290 births
    • DOI 10.1016/S0140-6736(00)05112-6
    • Smith GC, Pell JP, Walsh D. Pregnancy complications and maternal risk of ischaemic heart disease: A retrospective cohort study of 129,290 births. Lancet 2001;357:2002-6. (Pubitemid 32592386)
    • (2001) Lancet , vol.357 , Issue.9273 , pp. 2002-2006
    • Smith, G.C.S.1    Pell, J.P.2    Walsh, D.3
  • 7
    • 35548980979 scopus 로고    scopus 로고
    • Hypertension in pregnancy: An emerging risk factor for cardiovascular disease
    • DOI 10.1038/ncpneph0623, PII NCPNEPH0623
    • Garovic VD, Hayman SR. Hypertension in pregnancy: An emerging risk factor for cardiovascular disease. Nat Clin Pract Nephrol 2007;3: 613-22. (Pubitemid 350012820)
    • (2007) Nature Clinical Practice Nephrology , vol.3 , Issue.11 , pp. 613-622
    • Garovic, V.D.1    Hayman, S.R.2
  • 8
    • 79959507759 scopus 로고    scopus 로고
    • Preeclampsia, a disease of the maternal endothelium: The role of antiangiogenic factors and implications for later cardiovascular disease
    • Powe CE, Levine RJ, Karumanchi SA. Preeclampsia, a disease of the maternal endothelium: The role of antiangiogenic factors and implications for later cardiovascular disease. Circulation 123: 2856-69.
    • Circulation , vol.123 , pp. 2856-69
    • Powe, C.E.1    Levine, R.J.2    Karumanchi, S.A.3
  • 13
    • 39649122843 scopus 로고    scopus 로고
    • A preeclampsia-like syndrome characterized by reversible hypertension and proteinuria induced by the multitargeted kinase inhibitors sunitinib and sorafenib
    • DOI 10.1093/jnci/djm311
    • Patel TV, Morgan JA, Demetri GD, George S, Maki RG, Quigley M, Humphreys BD. A preeclampsialike syndrome characterized by reversible hypertension and proteinuria induced by the multitargeted kinase inhibitors sunitinib and sorafenib. J Natl Cancer Inst 2008;100:282-4. (Pubitemid 351480534)
    • (2008) Journal of the National Cancer Institute , vol.100 , Issue.4 , pp. 282-284
    • Patel, T.V.1    Morgan, J.A.2    Demetri, G.D.3    George, S.4    Maki, R.G.5    Quigley, M.6    Humphreys, B.D.7
  • 17
    • 7244238090 scopus 로고    scopus 로고
    • Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia
    • DOI 10.1161/01.RES.0000147365.86159.f5
    • Ahmad S, Ahmed A. Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia. Circ Res 2004;95:884-91. (Pubitemid 39435003)
    • (2004) Circulation Research , vol.95 , Issue.9 , pp. 884-891
    • Ahmad, S.1    Ahmed, A.2
  • 20
    • 18044370643 scopus 로고    scopus 로고
    • Circulating angiogenic factors in preeclampsia
    • DOI 10.1097/01.grf.0000160313.82606.d7
    • Levine RJ, Karumanchi SA. Circulating angiogenic factors in preeclampsia. Clin Obstet Gynecol 2005;48:372-86. (Pubitemid 40605141)
    • (2005) Clinical Obstetrics and Gynecology , vol.48 , Issue.2 , pp. 372-386
    • Levine, R.J.1    Karumanchi, S.A.2
  • 21
    • 77955145573 scopus 로고    scopus 로고
    • Reduction of circulating soluble Flt-1 alleviates preeclampsialike symptoms in a mouse model
    • Bergmann A, Ahmad S, Cudmore M, Gruber AD, Wittschen P, Lindenmaier W, et al. Reduction of circulating soluble Flt-1 alleviates preeclampsialike symptoms in a mouse model. J Cell Mol Med 2010;14:1857-67.
    • (2010) J Cell Mol Med , vol.4 , pp. 1857-1867
    • Bergmann, A.1    Ahmad, S.2    Cudmore, M.3    Gruber, A.D.4    Wittschen, P.5    Lindenmaier, W.6
  • 22
    • 36448996940 scopus 로고    scopus 로고
    • Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble fms-like tyrosine kinase-1 expression
    • DOI 10.1161/HYPERTENSIONAHA.107.096594
    • Gilbert JS, Babcock SA, Granger JP. Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble fms-like tyrosine kinase-1 expression. Hypertension 2007;50:1142-7. (Pubitemid 350172938)
    • (2007) Hypertension , vol.50 , Issue.6 , pp. 1142-1147
    • Gilbert, J.S.1    Babcock, S.A.2    Granger, J.P.3
  • 24
    • 33947619480 scopus 로고    scopus 로고
    • The effect of over-expression of sFlt-1 on blood pressure and the occurrence of other manifestations of preeclampsia in unrestrained conscious pregnant mice
    • e1-7
    • Lu F, Longo M, Tamayo E, Maner W, Al-Hendy A, Anderson GD, et al. The effect of over-expression of sFlt-1 on blood pressure and the occurrence of other manifestations of preeclampsia in unrestrained conscious pregnant mice. Am J Obstet Gynecol 2007;196:396 e1-7.
    • (2007) Am J Obstet Gynecol , vol.196 , pp. 396
    • Lu, F.1    Longo, M.2    Tamayo, E.3    Maner, W.4    Al-Hendy, A.5    Anderson, G.D.6
  • 27
    • 4344564076 scopus 로고    scopus 로고
    • Maternal serum sFlt1 concentration is an early and reliable predictive marker of preeclampsia [1]
    • DOI 10.1373/clinchem.2004.036715
    • Hertig A, Berkane N, Lefevre G, Toumi K, Marti HP, Capeau J, et al. Maternal serum sFlt1 concentration is an early and reliable predictive marker of preeclampsia. Clin Chem 2004;50: 1702-3. (Pubitemid 39121252)
    • (2004) Clinical Chemistry , vol.50 , Issue.9 , pp. 1702-1703
    • Hertig, A.1    Berkane, N.2    Lefevre, G.3    Toumi, K.4    Marti, H.-P.5    Capeau, J.6    Uzan, S.7    Rondeau, E.8
  • 32
    • 79251528214 scopus 로고    scopus 로고
    • New insights into the etiology of preeclampsia: Identification of key elusive factors for the vascular complications
    • Ahmed A. New insights into the etiology of preeclampsia: Identification of key elusive factors for the vascular complications. Thromb Res 2011; 127(Suppl 3):S72-5.
    • (2011) Thromb Res , vol.127 , Issue.SUPPL. 3
    • Ahmed, A.1
  • 35
    • 77955417702 scopus 로고    scopus 로고
    • Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension
    • Noori M, Donald AE, Angelakopoulou A, Hingorani AD, Williams DJ. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension. Circulation 122:478-87.
    • Circulation , vol.122 , pp. 478-87
    • Noori, M.1    Donald, A.E.2    Angelakopoulou, A.3    Hingorani, A.D.4    Williams, D.J.5
  • 36
    • 37849021866 scopus 로고    scopus 로고
    • A longitudinal study of angiogenic (placental growth factor) and anti-Angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate
    • Romero R, Nien JK, Espinoza J, Todem D, Fu W, Chung H, et al. A longitudinal study of angiogenic (placental growth factor) and anti-Angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med 2008;21: 9-23.
    • (2008) J Matern Fetal Neonatal Med , vol.21 , pp. 9-23
    • Romero, R.1    Nien, J.K.2    Espinoza, J.3    Todem, D.4    Fu, W.5    Chung, H.6
  • 37
    • 0037245823 scopus 로고    scopus 로고
    • Longitudinal serum concentrations of placental growth factor: Evidence for abnormal placental angiogenesis in pathologic pregnancies
    • DOI 10.1067/mob.2003.111
    • Taylor RN, Grimwood J, Taylor RS, McMaster MT, Fisher SJ, North RA. Longitudinal serum concentrations of placental growth factor: Evidence for abnormal placental angiogenesis in pathologic pregnancies. Am J Obstet Gynecol 2003;188: 177-82. (Pubitemid 36135616)
    • (2003) American Journal of Obstetrics and Gynecology , vol.188 , Issue.1 , pp. 177-182
    • Taylor, R.N.1    Grimwood, J.2    Taylor, R.S.3    McMaster, M.T.4    Fisher, S.J.5    North, R.A.6
  • 39
    • 20344396618 scopus 로고    scopus 로고
    • Prediction of preeclampsia with maternal mid-trimester placental growth factor, activin A, fibronectin and uterine artery Doppler velocimetry
    • DOI 10.1016/j.ijgo.2005.02.008, PII S0020729205001621
    • Madazli R, Kuseyrioglu B, Uzun H, Uludag S, Ocak V. Prediction of preeclampsia with maternal midtrimester placental growth factor, activin a, fibronectin and uterine artery doppler velocimetry. Int J Gynaecol Obstet 2005;89:251-7. (Pubitemid 40779295)
    • (2005) International Journal of Gynecology and Obstetrics , vol.89 , Issue.3 , pp. 251-257
    • Madazli, R.1    Kuseyrioglu, B.2    Uzun, H.3    Uludag, S.4    Ocak, V.5
  • 41
    • 47749139356 scopus 로고    scopus 로고
    • Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors
    • Lim JH, Kim SY, Park SY, Yang JH, Kim MY, Ryu HM. Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors. Obstet Gynecol 2008;111:1403-9.
    • (2008) Obstet Gynecol , vol.111 , pp. 1403-9
    • Lim, J.H.1    Kim, S.Y.2    Park, S.Y.3    Yang, J.H.4    Kim, M.Y.5    Ryu, H.M.6
  • 43
    • 50349085834 scopus 로고    scopus 로고
    • First-Trimester serum levels of soluble endoglin and soluble fms-like tyrosine kinase-1 as first-Trimester markers for late-onset preeclampsia
    • Baumann MU, Bersinger NA, Mohaupt MG, Raio L, Gerber S, Surbek DV. First-Trimester serum levels of soluble endoglin and soluble fms-like tyrosine kinase-1 as first-Trimester markers for late-onset preeclampsia. Am J Obstet Gynecol 2008;199:266 e1-6.
    • (2008) Am J Obstet Gynecol , vol.199
    • Baumann, M.U.1    Bersinger, N.A.2    Mohaupt, M.G.3    Raio, L.4    Gerber, S.5    Surbek, D.V.6
  • 44
    • 34249874048 scopus 로고    scopus 로고
    • Circulating angiogenic factors in early pregnancy and the risk of preeclampsia, intrauterine growth restriction, spontaneous preterm birth, and stillbirth
    • DOI 10.1097/01.AOG.0000265804.09161.0d, PII 0000625020070600000010
    • Smith GC, Crossley JA, Aitken DA, Jenkins N, Lyall F, Cameron AD, et al. Circulating angiogenic factors in early pregnancy and the risk of preeclampsia, intrauterine growth restriction, spontaneous preterm birth, and stillbirth. Obstet Gynecol 2007;109:1316-24. (Pubitemid 46869870)
    • (2007) Obstetrics and Gynecology , vol.109 , Issue.6 , pp. 1316-1324
    • Smith, G.C.S.1    Crossley, J.A.2    Aitken, D.A.3    Jenkins, N.4    Lyall, F.5    Cameron, A.D.6    Connor, J.M.7    Dobbie, R.8
  • 45
    • 34250858133 scopus 로고    scopus 로고
    • Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia
    • DOI 10.1161/HYPERTENSIONAHA.107.087700, PII 0000426820070700000024
    • Rana S, Karumanchi SA, Levine RJ, Venkatesha S, Rauh-Hain JA, Tamez H, Thadhani R. Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia. Hypertension 2007;50:137-42. (Pubitemid 46986022)
    • (2007) Hypertension , vol.50 , Issue.1 , pp. 137-142
    • Rana, S.1    Karumanchi, S.A.2    Levine, R.J.3    Venkatesha, S.4    Rauh-Hain, J.A.5    Tamez, H.6    Thadhani, R.7
  • 46
    • 56249113278 scopus 로고    scopus 로고
    • Screening for placental insufficiency in high-risk pregnancies: Is earlier better?
    • Costa SL, Proctor L, Dodd JM, Toal M, Okun N, Johnson JA, et al. Screening for placental insufficiency in high-risk pregnancies: Is earlier better? Placenta 2008;29:1034-40.
    • (2008) Placenta , vol.29 , pp. 1034-40
    • Costa, S.L.1    Proctor, L.2    Dodd, J.M.3    Toal, M.4    Okun, N.5    Johnson, J.A.6
  • 48
    • 33847618756 scopus 로고    scopus 로고
    • Changes in circulating level of angiogenic factors from the first to second trimester as predictors of preeclampsia
    • e1-6
    • Vatten LJ, Eskild A, Nilsen TI, Jeansson S, Jenum PA, Staff AC. Changes in circulating level of angiogenic factors from the first to second trimester as predictors of preeclampsia. Am J Obstet Gynecol 2007;196:239 e1-6.
    • (2007) Am J Obstet Gynecol , vol.196 , pp. 239
    • Vatten, L.J.1    Eskild, A.2    Nilsen, T.I.3    Jeansson, S.4    Jenum, P.A.5    Staff, A.C.6
  • 49
    • 70350320956 scopus 로고    scopus 로고
    • A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-Angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia
    • Kusanovic JP, Romero R, Chaiworapongsa T, Erez O, Mittal P, Vaisbuch E, et al. A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-Angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia. J Matern Fetal Neonatal Med 2009; 22:1021-38.
    • (2009) J Matern Fetal Neonatal Med , vol.22 , pp. 1021-38
    • Kusanovic, J.P.1    Romero, R.2    Chaiworapongsa, T.3    Erez, O.4    Mittal, P.5    Vaisbuch, E.6
  • 51
    • 84857634410 scopus 로고    scopus 로고
    • Angiogenic factors in superimposed preeclampsia: A longitudinal study of women with chronic hypertension during pregnancy
    • Perni U, Sison C, Sharma V, Helseth G, Hawfield A, Suthanthiran M, August P. Angiogenic factors in superimposed preeclampsia: A longitudinal study of women with chronic hypertension during pregnancy. Hypertension 2012;59:740-6.
    • (2012) Hypertension , vol.59 , pp. 740-6
    • Perni, U.1    Sison, C.2    Sharma, V.3    Helseth, G.4    Hawfield, A.5    Suthanthiran, M.6    August, P.7
  • 52
    • 78149431733 scopus 로고    scopus 로고
    • Soluble fms-like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies
    • Powers RW, Jeyabalan A, Clifton RG, Van Dorsten P, Hauth JC, Klebanoff MA, et al. Soluble fms-like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies. PLoS One 2010;5:e13263.
    • (2010) PLoS One , vol.5
    • Powers, R.W.1    Jeyabalan, A.2    Clifton, R.G.3    Van Dorsten, P.4    Hauth, J.C.5    Klebanoff, M.A.6
  • 53
    • 50349089750 scopus 로고    scopus 로고
    • Serum inhibin a and angiogenic factor levels in pregnancies with previous preeclampsia and/or chronic hypertension are they useful markers for prediction of subsequent preeclampsia?
    • e1-9
    • Sibai BM, Koch MA, Freire S, Pinto e Silva JL, Rudge MV, Martins-Costa S, et al. Serum inhibin a and angiogenic factor levels in pregnancies with previous preeclampsia and/or chronic hypertension: Are they useful markers for prediction of subsequent preeclampsia? Am J Obstet Gynecol 2008;199:268 e1-9.
    • (2008) Am J Obstet Gynecol , vol.199 , pp. 268
    • Sibai, B.M.1    Koch, M.A.2    Freire, S.3    Pintoe Silva, J.L.4    Rudge, M.V.5    Martins-Costa, S.6
  • 54
    • 49949114898 scopus 로고    scopus 로고
    • Predictive value of angiogenic factors and uterine artery doppler for earlyversus late-onset pre-eclampsia and intrauterine growth restriction
    • Crispi F, Llurba E, Dominguez C, Martin-Gallan P, Cabero L, Gratacos E. Predictive value of angiogenic factors and uterine artery doppler for earlyversus late-onset pre-eclampsia and intrauterine growth restriction. Ultrasound Obstet Gynecol 2008;31:303-9.
    • (2008) Ultrasound Obstet Gynecol , vol.31 , pp. 303-9
    • Crispi, F.1    Llurba, E.2    Dominguez, C.3    Martin-Gallan, P.4    Cabero, L.5    Gratacos, E.6
  • 55
    • 46749094190 scopus 로고    scopus 로고
    • Angiogenic factors for the prediction of preeclampsia in women with abnormal midtrimester uterine artery doppler velocimetry
    • Diab AE, El-Behery MM, Ebrahiem MA, Shehata AE. Angiogenic factors for the prediction of preeclampsia in women with abnormal midtrimester uterine artery doppler velocimetry. Int J Gynaecol Obstet 2008;102:146-51.
    • (2008) Int J Gynaecol Obstet , vol.102 , pp. 146-51
    • Diab, A.E.1    El-Behery, M.M.2    Ebrahiem, M.A.3    Shehata, A.E.4
  • 56
    • 33947679731 scopus 로고    scopus 로고
    • Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery doppler velocimetry and placental growth factor
    • Espinoza J, Romero R, Nien JK, Gomez R, Kusanovic JP, Goncalves LF, et al. Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery doppler velocimetry and placental growth factor. Am J Obstet Gynecol 2007;196:326 e1-13.
    • (2007) Am J Obstet Gynecol , vol.196
    • Espinoza, J.1    Romero, R.2    Nien, J.K.3    Gomez, R.4    Kusanovic, J.P.5    Goncalves, L.F.6
  • 57
    • 38349087878 scopus 로고    scopus 로고
    • Circulatory soluble endoglin and its predictive value for preeclampsia in secondtrimester pregnancies with abnormal uterine perfusion
    • Stepan H, Geipel A, Schwarz F, Kramer T, Wessel N, Faber R. Circulatory soluble endoglin and its predictive value for preeclampsia in secondtrimester pregnancies with abnormal uterine perfusion. Am J Obstet Gynecol 2008;198:175 e1-6.
    • (2008) Am J Obstet Gynecol , vol.198
    • Stepan, H.1    Geipel, A.2    Schwarz, F.3    Kramer, T.4    Wessel, N.5    Faber, R.6
  • 58
    • 34047232484 scopus 로고    scopus 로고
    • Predictive value of maternal angiogenic factors in second trimester pregnancies with abnormal uterine perfusion
    • DOI 10.1161/01.HYP.0000258404.21552.a3
    • Stepan H, Unversucht A, Wessel N, Faber R. Predictive value of maternal angiogenic factors in second trimester pregnancies with abnormal uterine perfusion. Hypertension 2007;49:818-24. (Pubitemid 351664216)
    • (2007) Hypertension , vol.49 , Issue.4 , pp. 818-824
    • Stepan, H.1    Unversucht, A.2    Wessel, N.3    Faber, R.4
  • 59
    • 34347249118 scopus 로고    scopus 로고
    • Diagnostic utility of soluble fms-like tyrosine kinase 1 and soluble endoglin in hypertensive diseases of pregnancy
    • Salahuddin S, Lee Y, Vadnais M, Sachs BP, Karumanchi SA, Lim KH. Diagnostic utility of soluble fms-like tyrosine kinase 1 and soluble endoglin in hypertensive diseases of pregnancy. Am J Obstet Gynecol 2007;197:28 e1-6.
    • (2007) Am J Obstet Gynecol , vol.197
    • Salahuddin, S.1    Lee, Y.2    Vadnais, M.3    Sachs, B.P.4    Karumanchi, S.A.5    Lim, K.H.6
  • 60
    • 3442884269 scopus 로고    scopus 로고
    • Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award
    • Chaiworapongsa T, Romero R, Espinoza J, Bujold E, Mee Kim Y, Goncalves LF, et al. Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award. Am J Obstet Gynecol 2004;190:1541-7.
    • (2004) Am J Obstet Gynecol , vol.190 , pp. 1541-7
    • Chaiworapongsa, T.1    Romero, R.2    Espinoza, J.3    Bujold, E.4    Mee Kim, Y.5    Goncalves, L.F.6
  • 61
    • 80053958768 scopus 로고    scopus 로고
    • Fetal endothelium dysfunction is associated with circulating maternal levels of sE-selectin, sVCAM1, and sFlt-1 during pre-eclampsia
    • Veas CJ, Aguilera VC, Munoz IJ, Gallardo VI, Miguel PL, Gonzalez MA, et al. Fetal endothelium dysfunction is associated with circulating maternal levels of sE-selectin, sVCAM1, and sFlt-1 during pre-eclampsia. J Matern Fetal Neonatal Med 2011;24:1371-7.
    • (2011) J Matern Fetal Neonatal Med , vol.24 , pp. 1371-7
    • Veas, C.J.1    Aguilera, V.C.2    Munoz, I.J.3    Gallardo, V.I.4    Miguel, P.L.5    Gonzalez, M.A.6
  • 62
    • 34249908643 scopus 로고    scopus 로고
    • Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia
    • DOI 10.1097/01.AOG.0000264552.85436.a1, PII 0000625020070600000016
    • Wikstrom AK, Larsson A, Eriksson UJ, Nash P, Norden-Lindeberg S, Olovsson M. Placental growth factor and soluble fms-like tyrosine kinase-1 in early-onset and late-onset preeclampsia. Obstet Gynecol 2007;109:1368-74. (Pubitemid 46869876)
    • (2007) Obstetrics and Gynecology , vol.109 , Issue.6 , pp. 1368-1374
    • Wikstrom, A.-K.1    Larsson, A.2    Eriksson, U.J.3    Nash, P.4    Norden-Lindeberg, S.5    Olovsson, M.6
  • 64
    • 59849123575 scopus 로고    scopus 로고
    • Prevalence of agonistic autoantibodies against the angiotensin II type 1 receptor and soluble fms-like tyrosine kinase 1 in a gestational age-matched case study
    • Herse F, Verlohren S, Wenzel K, Pape J, Muller DN, Modrow S, et al. Prevalence of agonistic autoantibodies against the angiotensin II type 1 receptor and soluble fms-like tyrosine kinase 1 in a gestational age-matched case study. Hypertension 2009;53:393-8.
    • (2009) Hypertension , vol.53 , pp. 393-8
    • Herse, F.1    Verlohren, S.2    Wenzel, K.3    Pape, J.4    Muller, D.N.5    Modrow, S.6
  • 65
    • 66849106737 scopus 로고    scopus 로고
    • The relationship of the level of circulating antiangiogenic factors to the clinical manifestations of preeclampsia
    • Kim YN, Lee DS, Jeong DH, Sung MS, Kim KT. The relationship of the level of circulating antiangiogenic factors to the clinical manifestations of preeclampsia. Prenat Diagn 2009;29:464-70.
    • (2009) Prenat Diagn , vol.29 , pp. 464-70
    • Kim, Y.N.1    Lee, D.S.2    Jeong, D.H.3    Sung, M.S.4    Kim, K.T.5
  • 66
    • 74549205785 scopus 로고    scopus 로고
    • Different profiles of circulating angiogenic factors and adipocytokines between early-And late-onset preeclampsia
    • Masuyama H, Segawa T, Sumida Y, Masumoto A, Inoue S, Akahori Y, Hiramatsu Y. Different profiles of circulating angiogenic factors and adipocytokines between early-And late-onset preeclampsia. BJOG 117:314-20.
    • BJOG , vol.117 , pp. 314-20
    • Masuyama, H.1    Segawa, T.2    Sumida, Y.3    Masumoto, A.4    Inoue, S.5    Akahori, Y.6    Hiramatsu, Y.7
  • 67
    • 55149097472 scopus 로고    scopus 로고
    • Soluble and membranous vascular endothelial growth factor receptor-1 in pregnancies complicated by preeclampsia
    • Tripathi R, Rath G, Jain A, Salhan S. Soluble and membranous vascular endothelial growth factor receptor-1 in pregnancies complicated by preeclampsia. Ann Anat 2008;190:477-89.
    • (2008) Ann Anat , vol.190 , pp. 477-89
    • Tripathi, R.1    Rath, G.2    Jain, A.3    Salhan, S.4
  • 68
    • 34047196414 scopus 로고    scopus 로고
    • Alterations in placental growth factor levels before and after the onset of preeclampsia are more pronounced in women with early onset severe preeclampsia
    • DOI 10.1291/hypres.30.151
    • Ohkuchi A, Hirashima C, Matsubara S, Suzuki H, Takahashi K, Arai F, et al. Alterations in placental growth factor levels before and after the onset of preeclampsia are more pronounced in women with early onset severe preeclampsia. Hypertens Res 2007;30:151-9. (Pubitemid 46541789)
    • (2007) Hypertension Research , vol.30 , Issue.2 , pp. 151-159
    • Ohkuchi, A.1    Hirashima, C.2    Matsubara, S.3    Suzuki, H.4    Takahashi, K.5    Arai, F.6    Watanabe, T.7    Kario, K.8    Suzuki, M.9
  • 69
    • 80255122679 scopus 로고    scopus 로고
    • Angiogenic factors as diagnostic tests for preeclampsia: A performance comparison between two commercial immunoassays
    • Benton SJ, Hu Y, Xie F, Kupfer K, Lee SW, Magee LA, von Dadelszen P. Angiogenic factors as diagnostic tests for preeclampsia: A performance comparison between two commercial immunoassays. Am J Obstet Gynecol 2011;205:469.e1-8.
    • (2011) Am J Obstet Gynecol , vol.205
    • Benton, S.J.1    Hu, Y.2    Xie, F.3    Kupfer, K.4    Lee, S.W.5    Magee, L.A.6    Von Dadelszen, P.7
  • 70
    • 77951945121 scopus 로고    scopus 로고
    • Evaluation of a new and automated electrochemiluminescence immunoassay for plasma sFlt-1 and PlGF levels in women with preeclampsia
    • Ohkuchi A, Hirashima C, Suzuki H, Takahashi K, Yoshida M, Matsubara S, Suzuki M. Evaluation of a new and automated electrochemiluminescence immunoassay for plasma sFlt-1 and PlGF levels in women with preeclampsia. Hypertens Res 2010; 33:422-7.
    • (2010) Hypertens Res , vol.33 , pp. 422-7
    • Ohkuchi, A.1    Hirashima, C.2    Suzuki, H.3    Takahashi, K.4    Yoshida, M.5    Matsubara, S.6    Suzuki, M.7
  • 71
    • 77952953001 scopus 로고    scopus 로고
    • Multicenter evaluation of the first automated elecsys sFlt-1 and PlGF assays in normal pregnancies and preeclampsia
    • Schiettecatte J, Russcher H, Anckaert E, Mees M, Leeser B, Tirelli AS, et al. Multicenter evaluation of the first automated elecsys sFlt-1 and PlGF assays in normal pregnancies and preeclampsia. Clin Biochem 2010;43:768-70.
    • (2010) Clin Biochem , vol.43 , pp. 768-70
    • Schiettecatte, J.1    Russcher, H.2    Anckaert, E.3    Mees, M.4    Leeser, B.5    Tirelli, A.S.6
  • 73
    • 79952949639 scopus 로고    scopus 로고
    • Measurement of sVEGF R1 and PlGF in serum: Comparing prototype assays from Beckman Coulter, Inc. to R&D systems microplate assays
    • Wothe D, Gaziano E, Sunderji S, Romero R, Kusanovic JP, Rogers L, et al. Measurement of sVEGF R1 and PlGF in serum: Comparing prototype assays from Beckman Coulter, Inc. to R&D systems microplate assays. Hypertens Pregnancy 2011;30:18-27.
    • (2011) Hypertens Pregnancy , vol.30 , pp. 18-27
    • Wothe, D.1    Gaziano, E.2    Sunderji, S.3    Romero, R.4    Kusanovic, J.P.5    Rogers, L.6
  • 74
    • 80555143068 scopus 로고    scopus 로고
    • Angiogenic growth factors in the diagnosis and prediction of pre-eclampsia
    • Verlohren S, Stepan H, Dechend R. Angiogenic growth factors in the diagnosis and prediction of pre-eclampsia. Clin Sci 2012;122:43-52.
    • (2012) Clin Sci , vol.122 , pp. 43-52
    • Verlohren, S.1    Stepan, H.2    Dechend, R.3
  • 76
    • 0036246353 scopus 로고    scopus 로고
    • Mortality in low birth weight infants according to level of neonatal care at hospital of birth
    • DOI 10.1542/peds.109.5.745
    • Cifuentes J, Bronstein J, Phibbs CS, Phibbs RH, Schmitt SK, Carlo WA. Mortality in low birth weight infants according to level of neonatal care at hospital of birth. Pediatrics 2002;109:745-51. (Pubitemid 34493337)
    • (2002) Pediatrics , vol.109 , Issue.5 , pp. 745-751
    • Cifuentes, J.1    Bronstein, J.2    Phibbs, C.S.3    Phibbs, R.H.4    Schmitt, S.K.5    Carlo, W.A.6
  • 78
    • 34249001303 scopus 로고    scopus 로고
    • Antiplatelet agents for prevention of pre-eclampsia: A meta-analysis of individual patient data
    • DOI 10.1016/S0140-6736(07)60712-0, PII S0140673607607120
    • Askie LM, Duley L, Henderson-Smart DJ, Stewart LA. Antiplatelet agents for prevention of preeclampsia: A meta-Analysis of individual patient data. Lancet 2007;369:1791-8. (Pubitemid 46782996)
    • (2007) Lancet , vol.369 , Issue.9575 , pp. 1791-1798
    • Askie, L.M.1    Duley, L.2    Henderson-Smart, D.J.3    Stewart, L.A.4
  • 79
    • 80052149662 scopus 로고    scopus 로고
    • Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia
    • Thadhani R, Kisner T, Hagmann H, Bossung V, Noack S, Schaarschmidt W, et al. Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia. Circulation 2011; 124:940-50.
    • (2011) Circulation , vol.124 , pp. 940-50
    • Thadhani, R.1    Kisner, T.2    Hagmann, H.3    Bossung, V.4    Noack, S.5    Schaarschmidt, W.6
  • 81
    • 78650950716 scopus 로고    scopus 로고
    • Use of angiogenic factors (sFlt-1/PlGF ratio) to confirm the diagnosis of preeclampsia in clinical routine: First experience]
    • [German]
    • Stepan H, Schaarschmidt W, Jank A, Verlohren S, Kratzsch J. [Use of angiogenic factors (sFlt-1/PlGF ratio) to confirm the diagnosis of preeclampsia in clinical routine: First experience]. Z Geburtshilfe Neonatol 2010;214:234-8. [German]
    • (2010) Z Geburtshilfe Neonatol , vol.214 , pp. 234-8
    • Stepan, H.1    Schaarschmidt, W.2    Jank, A.3    Verlohren, S.4    Kratzsch, J.5
  • 82
    • 84455208308 scopus 로고    scopus 로고
    • The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients
    • Verlohren S, Herraiz I, Lapaire O, Schlembach D, Moertl M, Zeisler H, et al. The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients. Am J Obstet Gynecol 2012;206:58 e1-8.
    • (2012) Am J Obstet Gynecol , vol.206
    • Verlohren, S.1    Herraiz, I.2    Lapaire, O.3    Schlembach, D.4    Moertl, M.5    Zeisler, H.6
  • 83
    • 80052974205 scopus 로고    scopus 로고
    • Maternal plasma concentrations of angiogenic/antiangiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia
    • Chaiworapongsa T, Romero R, Savasan ZA, Kusanovic JP, Ogge G, Soto E, et al. Maternal plasma concentrations of angiogenic/antiangiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia. J Matern Fetal Neonatal Med 2011;24:1187-207.
    • (2011) J Matern Fetal Neonatal Med , vol.24 , pp. 1187-207
    • Chaiworapongsa, T.1    Romero, R.2    Savasan, Z.A.3    Kusanovic, J.P.4    Ogge, G.5    Soto, E.6
  • 84
    • 84857594613 scopus 로고    scopus 로고
    • Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia
    • Rana S, Powe CE, Salahuddin S, Verlohren S, Perschel FH, Levine RJ, et al. Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia. Circulation 2012:125: 911-9.
    • (2012) Circulation , vol.125 , pp. 911-9
    • Rana, S.1    Powe, C.E.2    Salahuddin, S.3    Verlohren, S.4    Perschel, F.H.5    Levine, R.J.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.